P
Pharmazz
This biopharmaceutical company focuses on discovering, developing, and commercializing therapeutics for critical care medicine. The pipeline features endothelin-based drug candidates targeting severe conditions like cerebral ischemic stroke and hypovolemic shock. They offer an approved resuscitative agent, Centhaquine (Lyfaquin), currently marketed in India for hypovolemic shock.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This biopharmaceutical company focuses on discovering, developing, and commercializing therapeutics for critical care medicine. The pipeline features endothelin-based drug candidates targeting severe conditions like cerebral ischemic stroke and hypovolemic shock. They offer an approved resuscitative agent, Centhaquine (Lyfaquin), currently marketed in India for hypovolemic shock.